Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: S&P Capital IQ Quantitative Report
$127.00
Provider: ValuEngine, Inc.
$25.00
Provider: New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Solazyme Inc Issues FY 2012 Revenue Guidance Below Analysts' Estimates-Conference Call


Wednesday, 14 Nov 2012 04:00pm EST 

Solazyme Inc announced that for fiscal 2012, it expects fiscal 2012 revenues to be up approximately 15% compared to fiscal 2011 to $44 million on the year. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $47 million for fiscal 2012. 

Company Quote

7.91
-0.34 -4.12%
4:00pm EDT